$297.55
0.08% yesterday
NYSE, May 12, 10:10 pm CET
ISIN
US70975L1070
Symbol
PEN

Penumbra, Inc. Stock price

$297.55
+27.28 10.09% 1M
+61.33 25.96% 6M
+60.07 25.29% YTD
+92.78 45.31% 1Y
+161.75 119.11% 3Y
+116.71 64.54% 5Y
+256.25 620.46% 10Y
NYSE, Closing price Mon, May 12 2025
+0.23 0.08%
ISIN
US70975L1070
Symbol
PEN
Sector

Key metrics

Market capitalization $11.51b
Enterprise Value $11.36b
P/E (TTM) P/E ratio 278.86
EV/FCF (TTM) EV/FCF 75.54
EV/Sales (TTM) EV/Sales 9.16
P/S ratio (TTM) P/S ratio 9.28
P/B ratio (TTM) P/B ratio 9.48
Revenue growth (TTM) Revenue growth 13.17%
Revenue (TTM) Revenue $1.24b
EBIT (operating result TTM) EBIT $114.47m
Free Cash Flow (TTM) Free Cash Flow $150.33m
Cash position $378.85m
EPS (TTM) EPS $1.07
P/E forward 75.34
P/S forward 8.49
EV/Sales forward 8.38
Short interest 5.57%
Show more

Is Penumbra, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,793 stocks worldwide.

Penumbra, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Penumbra, Inc. forecast:

15x Buy
71%
6x Hold
29%

Analyst Opinions

21 Analysts have issued a Penumbra, Inc. forecast:

Buy
71%
Hold
29%

Financial data from Penumbra, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,240 1,240
13% 13%
100%
- Direct Costs 453 453
15% 15%
37%
787 787
12% 12%
63%
- Selling and Administrative Expenses 555 555
14% 14%
45%
- Research and Development Expense 92 92
4% 4%
7%
139 139
9% 9%
11%
- Depreciation and Amortization 25 25
22% 22%
2%
EBIT (Operating Income) EBIT 114 114
19% 19%
9%
Net Profit 42 42
55% 55%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Penumbra, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Penumbra, Inc. Stock News

Positive
MarketBeat
6 days ago
While major market indexes like the S&P 500 have struggled to gain traction in 2025 and remain in the red YTD, certain pockets of the market are showing impressive strength. Several medical and biotechnology sector mid-cap stocks have stood out for their resilience and outperformance.
Neutral
PRNewsWire
13 days ago
ALAMEDA, Calif. , April 29, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025.
Positive
Seeking Alpha
13 days ago
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopharmaceutical quality control, new regulations, and product replacement cycles, targeting high single to low double-digit revenue growth. Penumbra's mechanical thrombectomy devices target underpenetr...
More Penumbra, Inc. News

Company Profile

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers thrombectomy, embolization, access, neurosurgical tools, ruby coil system, lantern, penumbra occlusion device (POD) system, packing coil, and indigo systems products. Its target markets include interventional neuroradiologists, neurosurgeons, and interventional neurologists; and interventional radiologists, vascular surgeons, and interventional cardiologists. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.

Head office United States
CEO Adam Elsesser
Employees 4,500
Founded 2004
Website www.penumbrainc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today